More about Chambal Fertilisers and Chemicals Limited
Fundamentals for Chambal Fertilisers and Chemicals Limited
Regulatory Filings for Chambal Fertilisers and Chemicals Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Chambal Fertilisers and Chemicals Limited
Business Operations:
Sector: Basic MaterialsIndustry: Agricultural Inputs
Chambal Fertilisers and Chemicals Limited, together with its subsidiaries, produces and sells fertilizers primarily in India. It offers urea; and other agri-inputs, such as di-ammonium phosphate, murate of potash, single super phosphate, and pesticides, as well as NPK fertilizers, specialty fertilizers and micro nutrients, insecticides, fungicides, and herbicides under the Uttam brand. The company was incorporated in 1985 and is headquartered in New Delhi, India.
Revenue projections:
CHAMBLFERT's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 10.455742 |
| debtToEquity | 1.022000 |
| earningsGrowth | 0.097000 |
| revenueGrowth | 0.199000 |
| grossMargins | 0.359610 |
| operatingMargins | 0.124270 |
| trailingEps | 47.790000 |
| forwardEps | 41.800000 |
CHAMBLFERT's Forward PE ratio suggests that the stock is priced appropriately in relation to its earnings. Not being overpriced, it offers room for growth, signaling potential upside for investors looking for a stock with reasonable valuation and growth potential.
CHAMBLFERT's forward EPS being lower than trailing EPS indicates reduced profitability in the upcoming year. This points to a potential decline in earnings, which could impact the company's financial strength.
Price projections:
CHAMBLFERT's current valuation aligns with projections, revealing no significant risks or opportunities. This stable environment may lead investors to adopt a wait-and-see strategy, monitoring future developments closely.
Recommendation changes over time:
CHAMBLFERT has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view CHAMBLFERT as a stable option to park their money and potentially benefit from the company's continued growth and profitability.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy